Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Real-World Clinical Outcomes In Patients Receiving Cyclin-Dependent Kinase 4/6 Inhibitors (Icdk 4/6) For Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (Hr+/Her2-) Metastatic Breast Cancer In Mexico.

Benigno Rodriguez,Lorena López Zepeda,Alejandro Noguez-Ramos,Daniela Vazquez Juarez,Christian Patricio Camacho Limas,Gabriela Olivia Regalado Porras,Ivonne Salcedo,Samuel Rivera,Alvaro Aguayo,Yazmin Carolina Blanco Vazquez, Angel Azael Lopez Galindo,Daniela Shveid Gerson,Fernando Perez-Zincer,Juan Alberto Serrano,José Fabián Martínez-Herrera,Guillermo Olivares,Alberto Villalobos, Cesar Gonzalez De Leon,Raquel Gerson

JOURNAL OF CLINICAL ONCOLOGY（2020）

Cited 0|Views7
No score
Abstract
e13053Background: Breast cancer was the second most common malignant tumor diagnosed in 2018 worldwide, and the main cause of cancer death in women. In Mexico is the leading cause of cancer deaths,...
More
Translated text
Key words
Metastatic Breast Cancer,CDK4/6 Inhibitors,Breast Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined